Klinik fanlar yilnomasi Том 2 № 3 (2025)

FEATURES OF THE CLINICAL COURSE OF SARCOPENIA IN METABOLICALLY ASSOCIATED FATTY LIVER DISEASE

Манзитова В.Ф

Читать на сайте источника PDF

Аннотация

Clinical studies demonstrate that the presence of sarcopenia in patients with NAFLD is associated with a poorer prognosis, including an increased risk of progressive liver fibrosis, reduced physical activity, and increased overall mortality. These findings highlight the need for a comprehensive approach to diagnosis and treatment that aims to identify sarcopenia in patients with NAFLD early and develop personalized treatment strategies that consider the interplay between these conditions.

sarcopenia; epidemiology; pathogenesis; comorbid conditions; insulin resistance; chronic inflammationсаркопения; эпидемиология; патогенез; коморбидные состояния; инсулинорезистентность; хроническое воспалениеsarkopeniya; epidemiologiya; patogenez; komorbid holatlar; insulin qarshiligi; surunkali yallig'lanish

Источник метаданных: OAI-PMH архив журнала · Sindex не хранит полный текст, а даёт ссылку на источник.

Цитировать

APA 7 
Манзитова В.Ф (2025). FEATURES OF THE CLINICAL COURSE OF SARCOPENIA IN METABOLICALLY ASSOCIATED FATTY LIVER DISEASE. Klinik fanlar yilnomasi, 2(3).
GOST R 7.0.5 
Манзитова В.Ф FEATURES OF THE CLINICAL COURSE OF SARCOPENIA IN METABOLICALLY ASSOCIATED FATTY LIVER DISEASE // Klinik fanlar yilnomasi. 2025. Т. 2. № 3.
BibTeX 
@article{в.ф2025,
  author  = {Манзитова В.Ф},
  title   = {FEATURES OF THE CLINICAL COURSE OF SARCOPENIA IN METABOLICALLY ASSOCIATED FATTY LIVER DISEASE},
  journal = {Klinik fanlar yilnomasi},
  year    = {2025},
  volume  = {2},
  number  = {3}
}
RIS 
TY  - JOUR
AU  - Манзитова В.Ф
TI  - FEATURES OF THE CLINICAL COURSE OF SARCOPENIA IN METABOLICALLY ASSOCIATED FATTY LIVER DISEASE
JO  - Klinik fanlar yilnomasi
PY  - 2025
VL  - 2
IS  - 3
ER  -